INS and Glucose intolerance: PPARγ is a special case as it acts both as an insulin sensitiser and adipogenic/lipogenic marker [23], thus the reductions of its expression in not only the liver but also Rp WAT in association with glucose intolerance and insulin resistance signals that its primary function leans toward promoting glucose homeostasis at this age [24].